Allspring Global Investments Holdings LLC trimmed its holdings in Amdocs Limited (NASDAQ:DOX – Free Report) by 5.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,019,884 shares of the technology company’s stock after selling 178,167 shares during the quarter. Allspring Global Investments Holdings LLC owned about 2.68% of Amdocs worth $278,403,000 as of its most recent SEC filing.
Other institutional investors have also bought and sold shares of the company. Cornerstone Planning Group LLC purchased a new position in Amdocs in the 1st quarter worth approximately $27,000. Quarry LP raised its position in shares of Amdocs by 42.2% during the 1st quarter. Quarry LP now owns 391 shares of the technology company’s stock valued at $36,000 after buying an additional 116 shares during the period. Cullen Frost Bankers Inc. acquired a new position in Amdocs in the first quarter valued at approximately $39,000. SVB Wealth LLC acquired a new position in Amdocs in the first quarter valued at approximately $43,000. Finally, Geneos Wealth Management Inc. lifted its holdings in Amdocs by 213.9% in the first quarter. Geneos Wealth Management Inc. now owns 700 shares of the technology company’s stock valued at $64,000 after acquiring an additional 477 shares during the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.
Amdocs Stock Down 1.3%
Shares of NASDAQ DOX opened at $80.77 on Monday. The firm has a market cap of $9.12 billion, a price-to-earnings ratio of 16.38, a PEG ratio of 1.34 and a beta of 0.51. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.23. Amdocs Limited has a 52-week low of $78.61 and a 52-week high of $95.41. The business’s 50 day moving average is $84.82 and its two-hundred day moving average is $87.68.
Amdocs Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be given a dividend of $0.527 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.6%. Amdocs’s dividend payout ratio is currently 42.80%.
Analysts Set New Price Targets
A number of research analysts recently commented on the company. Wall Street Zen upgraded Amdocs from a “hold” rating to a “buy” rating in a report on Saturday. Wolfe Research assumed coverage on Amdocs in a report on Tuesday, July 8th. They issued an “outperform” rating on the stock. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Amdocs in a report on Wednesday, October 8th. Three analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $108.00.
Read Our Latest Report on Amdocs
Amdocs Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Read More
- Five stocks we like better than Amdocs
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- Buy P&G Now, Before It Sets A New All-Time High
- Could Target’s Week of Discounts Come Full Circle for Investors?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
